Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

716.91 +12.60 (+1.79%)
Streaming Delayed Price Updated: 10:13 AM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded ↗
Additionally, the IBD SmartSelect Composite Rating for Argenx stock rose from 94 to a near best 96 Tuesday. 
Via Investor's Business Daily
Topics ETFs
News headline image
Assessing argenx: Insights From 11 Financial Analysts ↗
 
Via Benzinga
News headline image
Argenx Tops Buy Point On Bullish Study, 850 Price Target ↗
Argenx announced positive study results and plans to seek FDA approval to expand its label for Vyvgart. ARGX stock jumped as RBC initiated coverage. 
Via Investor's Business Daily
News headline image
Argenx Targets FDA Label Expansion After Vyvgart Trial Success ↗
Argenx reported positive Phase 3 Vyvgart data in seronegative myasthenia gravis, with plans for an FDA filing to expand the drug's label in 2025 
Via Benzinga
News headline image
argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
From argenx SE
Via GlobeNewswire
News headline image
Where argenx Stands With Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
argenx Earnings Preview ↗
 
Via Benzinga
News headline image
ARGENX SE - ADR (NASDAQ:ARGX) Ticks Key Boxes for Growth Investors Using Navellier's 'Little Book' Strategy ↗
Discover ARGX, a top growth stock matching Navellier's criteria with explosive earnings growth, soaring sales, and a high 21% ROE. 
Via Chartmill
News headline image
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
From argenx SE
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis
From argenx SE
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update
From argenx SE
Via GlobeNewswire
News headline image
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
argenx to Report Half Year 2025 Financial Results and Second Quarter Business Update on July 31, 2025
From argenx SE
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit ↗
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share. 
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
FDA Flags Major Safety Concerns For Argenx's Nerve Disorder Drug, Stock Falls ↗
FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.